Orion Group Holdings, Inc.
NYSE:ORNEngineering & Construction
+$0.48 today
- Market cap
- $300.07M
- Beta
- 1.38
- P/E (TTM)
- 73.6
- EPS (TTM)
- $0.21
Volume 0.92M
Average 0.34M
ORN Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
Orion Group Holdings, Inc.NYSE: ORN
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization grows, but more slowly than its trailing trend
Q1 FY2026 depreciation & amortization of $5.79M rose 7.1% year over year, behind the +17.6% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 20.4% from the prior quarter. Over 3 fiscal years it compounded at +8.3% a year.
Context
- Depreciation & amortization amounted to 3.6% of revenue in FY2025, up 0.7 pp from a year earlier.
- Depreciation & amortization increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +7.1% toward the trailing-twelve-month pace of +17.6%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the income statement
- Latest · FY2025
- 30.52M USD
- Year-over-year change
- +34.1%
- 4-year CAGR
- +4.7%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 30.52M | +34.1% |
| FY2024 | 2024-12-31 | 22.77M | -4.7% |
| FY2023 | 2023-12-31 | 23.88M | -0.7% |
| FY2022 | 2022-12-31 | 24.06M | -5.4% |
| FY2021 | 2021-12-31 | 25.43M | — |
Depreciation & Amortization vs competitors
How ORN compares with its peers on the latest reported figures
- Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +17.6% is the 4th highest of 10, against a peer median of +3.4%.
- Depreciation & amortization amounts to 3.0% of revenue for ORN, versus a peer median of 3.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Apr 2026 | $146.4M USD | +5.3% | +24.0% | 9.5% | |
| LTM Apr 2026 | $52.56M USD | -5.4% | -4.4% | 12.8% | |
| LTM Mar 2026 | $26.06M USD | +17.6% | +8.3% | 3.0% | |
| LTM Feb 2026 | $17.13M USD | +3.4% | -0.4% | 4.4% | |
SRTAStrata Critical Medical, Inc. | LTM Mar 2026 | $9.55M USD | +57.4% | +6.4% | 3.8% |
| LTM Mar 2026 | $9.18M USD | -10.2% | -13.1% | 1.1% | |
| LTM Mar 2026 | £2.88M GBP | — | -3.6% | — | |
| LTM Feb 2026 | $2.31M USD | +45.0% | +35.3% | 1.9% | |
| LTM Mar 2026 | $1.86M USD | +0.5% | +17.9% | 2.5% | |
| LTM Mar 2026 | $479K USD | +5222.2% | -22.1% | 2.6% | |
| LTM Apr 2026 | -$16.47M USD | -151.7% | — | 3.1% | |
| Peer median (excluding ORN) | — | +3.4% | -0.4% | 3.1% | |
Competitors are the stored peer set for ORN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 601.36M | 748.32M | 711.78M | 796.39M | 852.26M |
| Cost of Revenue | 560.39M | 697.58M | 650.12M | 705.23M | 746.65M |
| Gross Profit | 40.97M | 50.74M | 61.66M | 91.16M | 105.61M |
| Gross Margin | 6.8% | 6.8% | 8.7% | 11.4% | 12.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 60.18M | 62.5M | 69.43M | 82.54M | 93.47M |
| Operating Expenses | 50.28M | 58.77M | 68.29M | 79.64M | 93.47M |
| Depreciation & Amortization | 25.43M | 24.06M | 23.88M | 22.77M | 30.52M |
| EBITDA | 4.7M | 11.06M | 15.68M | 31.39M | 42.29M |
| EBITDA Margin | 0.8% | 1.5% | 2.2% | 3.9% | 5.0% |
| Operating Income | (9.32M) | (8.03M) | (6.63M) | 11.52M | 12.14M |
| Operating Margin | -1.5% | -1.1% | -0.9% | 1.4% | 1.4% |
| Interest Income | 136K | 104K | 103K | 207K | 0 |
| Interest Expense | 5.08M | 4.46M | 11.66M | 13.38M | 8.56M |
| Other Income / Expenses | (4.74M) | (4.15M) | (10.92M) | (12.82M) | (9.24M) |
| Income Before Tax | (14.06M) | (12.18M) | (17.55M) | (1.3M) | 2.91M |
| Pre-Tax Margin | -2.3% | -1.6% | -2.5% | -0.2% | 0.3% |
| Income Tax Expense | 502K | 429K | 330K | 348K | 419K |
| Net Income | (14.56M) | (12.61M) | (17.88M) | (1.64M) | 2.49M |
| Net Margin | -2.4% | -1.7% | -2.5% | -0.2% | 0.3% |
| EPS (Basic) | (0.47) | (0.40) | (0.55) | (0.05) | 0.06 |
| EPS (Diluted) | (0.47) | (0.40) | (0.55) | (0.05) | 0.06 |
| Weighted Avg Shares | 30.76M | 31.4M | 32.35M | 34.78M | 39.63M |
| Weighted Avg Shares (Diluted) | 30.76M | 31.4M | 32.35M | 34.78M | 39.64M |
Orion Group Holdings, Inc.
NYSE:ORN
Intrinsic Alpha fair value
Locked
Current Price
$7.38
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.